Form 4 for NUVB Nuvation Bio Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0002001938-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-02-27 | NUVB | Makunje Moses | SEE REMARKS | A - Grant | $0.00 | +50.8K | 68.1K | +292% | $0 |
| D | 2026-03-03 | 2026-02-27 | NUVB | Makunje Moses | SEE REMARKS | A - Grant | $0.00 | +224.4K | 224.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-27 | A | A | 50,761 | $0.00 | 68,137 | D | — | — | (F1) Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement. 25% of the shares subject to the RSUs shall vest on the Issuer's quarterly vesting date following each of the first four anniversaries from 2/27/2026, subject to Reporting Person's continuous service on each such vesting date. (F2) Includes 1,001 shares acquired on May 19, 2025 and 1,100 shares acquired November 19, 2025 under the 2021 Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-27 | A | A | 224,439 | $0.00 | 224,439 | D | $5.91 · — to 2036-02-26 | 224,439 Class A Common Stock | (F3) Option vests as to 25% on the one year anniversary of 2/27/26, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. |